Clinical Trials Browser

Metastatic Hormone-sensitive Prostate Cancer (mHSPC) × Androgen Antagonists × Clear all

NCT07216248 2025-10-29

OPTIMAS

Phase 2 Recruiting

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT06392841 2025-10-20

HARMONY

Phase 2 Withdrawn

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)